Abiomed
ABMD
#1257
Rank
NZ$29.73 B
Marketcap
NZ$659.55
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : NZ$0.27 Billion

According to Abiomed's latest financial reports the company's total liabilities are NZ$0.27 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31NZ$0.24 B4.01%
2021-03-31NZ$0.23 B-7.05%
2020-03-31NZ$0.25 B47.41%
2019-03-31NZ$0.17 B28.59%
2018-03-31NZ$0.13 B-4.54%
2017-03-31NZ$0.14 B75.95%
2016-03-31NZ$79.69 M26.77%
2015-03-31NZ$62.86 M47.21%
2014-03-31NZ$42.7 M8.67%
2013-03-31NZ$39.29 M16.82%
2012-03-31NZ$33.63 M-4.68%
2011-03-31NZ$35.29 M15.56%
2010-03-31NZ$30.53 M-13.32%
2009-03-31NZ$35.22 M15.9%
2008-03-31NZ$30.39 M54.39%
2007-03-31NZ$19.68 M31.68%
2006-03-31NZ$14.95 M117.87%
2005-03-31NZ$6.86 M-5.06%
2004-03-31NZ$7.22 M-35.93%
2003-03-31NZ$11.28 M-51.25%
2002-03-31NZ$23.14 M-1.55%
2001-03-31NZ$23.5 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
NZ$7.01 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$33.02 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$0.27 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA